Expression of the insulin-like growth factor-II mRNA-binding protein 3 (IMP3) and carcinoembryonic antigen (CEA) in mucinous minimal deviation adenocarcinoma

Pathology Research and Practice

Volumn 207, Issue 5, 2011, Pages 295-299

  He, Ying ^a   Li, Lei ^a   Jiang, Wei ^a   Wang, Dan qing ^a   Xu, Lian ^a   Huang, Qin ^a   Zhang, Yan ^a   Yang, Kai xuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

CEA; IMP3; Lobular endocervical glandular hyperplasia; Mucinous minimal deviation; P16INK4a

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; RNA BINDING PROTEIN; SOMATOMEDIN B MESSENGER RNA BINDING PROTEIN 3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOBULAR ENDOCERVICAL GLANDULAR HYPERPLASIA; MUCINOUS MINIMAL DEVIATION ADENOCARCINOMA; PROTEIN EXPRESSION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DISEASE;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; CERVIX UTERI; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; HYPERPLASIA; HYSTERECTOMY; MIDDLE AGED; PRECANCEROUS CONDITIONS; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS;

EID: 79955467895     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2011.02.011     Document Type: Article

References (23)

1. Kurman R.J., Norris H.J., Wilkinson E.J. Classification of tumors of the lower female genital tract. Atlas of Tumor Pathology. Tumors of the Cervix, Vagina, and Vulva 1992, 29-36. Armed Forces Institute of Pathology, Washington, DC. J. Rosai, L.H. Sobin (Eds.).
2. Nucci M.R., Clement P.B., Young R.H. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am. J. Surg. Pathol. 1999, 23:886-891.
3. Tsuda H, Mikami Y., Kaku T., Hasegawa T., Akiyama F., Ohishi Y., Sasajima Y., Kasamatsu T. Reproducible and clinically meaningful differential diagnosis is possible between lobular endocervical glandular hyperplasia and 'adenoma malignum' based on common histopathological criteria. Pathol. Int. 2005, 55:412-418.
4. Nielsen J., Christiansen J., Lykke-Andersen J., Johnsen A.H., Wewer U.M., Nielsen F.C. A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol. Cell Biol. 1999, 19:1262-1270.
5. Zheng W., Yi X., Fadare O., Liang S.X., Martel M., Schwartz P.E., Jiang Z. The oncofetal protein IMP3: A novel biomarker for endometrial serous carcinoma. Am. J. Surg. Pathol. 2008, 32:304-315.
6. Köbel M., Xu H., Bourne P.A., Spaulding B.O., Shih IeM., Mao T.L., Soslow R.A., Ewanowich C.A., Kalloger S.E., Mehl E., Lee C.H., Huntsman D., Gilks C.B. IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype. Mod. Pathol. 2009, 22:469-475.
7. Jiang Z., Chu P.G., Woda B.A., Rock K.L., Liu Q., Hsieh C.C., Li C., Chen W., Duan H.O., McDougal S., Wu C.L. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study. Lancet Oncol. 2006, 7:556-564.
8. Jeng Y.M., Chang C.C., Hu F.C., Chou H.Y., Kao H.L., Wang T.H., Hsu H.C. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma. Hepatology 2008, 48:1118-1127.
9. Do S.I., Kim Y.W., Park H.R., Park Y.K. Expression of insulin-like growth factor-II mRNA binding protein 3 (IMP3) in osteosarcoma. Oncol. Res. 2008, 17:269-272.
10. Michael H., Grawe L., Kraus F.T. Minimal deviation cervical adenocarcinoma: clinical and histologic features, immunohistochemical staining for carcinoembryonic antigen, and differentiation from confusing benign lesions. Int. J. Gynecol. Pathol. 1984, 3:261-276.
11. Steeper T.A, Wick M.R. Minimal deviation adenocarcinoma of the uterine cervix (" adenoma malignum" ). Cancer 1986, 58:1131-1138.
12. Ishii K., Hosaka N., Toki T., Momose M., Hidaka E., Tsuchiya S., Katsuyama T. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch. 1998, 432:315-322.
13. Keating J.T., Cviko A., Riethdorf S., Riethdorf L., Quade B.J., Sun D., Duensing S., Sheets E.E., Munger K., Crum C.P. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am. J. Surg. Pathol. 2001, 25:884-891.
14. Hashi A, Xu J.Y., Kondo T., Hashi K., Yuminamochi T., Nara M., Murata S., Katoh R., Hoshi K. P16INK4a overexpression independent of human papillomavirus infection in lobular endocervical glandular hyperplasia. Int. J. Gynecol. Pathol. 2006, 25:187-194.
15. Fattaneh A., Tavassoli, Peter Devilee Pathology and Genetics of Tumours of the Breast and Female Genital Organs 2003, International Agency for Research on Cancer (IARC), Lyon, France, p. 273.
16. Yantiss R.K., Woda B.A., Fanger G.R., Kalos M., Whalen G.F., Tada H., Andersen D.K., Rock K.L., Dresser K. KOC (k homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas. Am. J. Surg. Pathol. 2005, 29:188-195.
17. Vikesaa J., Hansen T.V., Jønson L., Borup R., Wewer U.M., Christiansen J., Nielsen F.C. RNA-binding IMPs promote cell adhesion and invadopodia formation. EMBO J. 2006, 25:1456-1468.
18. Li C., Rock K.L., Woda B.A., Jiang Z., Fraire A.E., Dresser K. IMP3 is a novel biomarker for adenocarcinoma in situ of the uterine cervix: an immunohistochemical study in comparison with p16INK4a expression. Mod. Pathol. 2007, 20:242-247.
19. Kawauchi S., Kusuda T., Liu X.P., Suehiro Y., Kaku T., Mikami Y., Takeshita M., Nakao M., Chochi Y., Sasaki K. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma? a comparative molecular-genetic and immunohistochemical study. Am. J. Surg. Pathol. 2008, 32:1807-1815.
20. Mikami Y., Hata S., Fujiwara K., Imajo Y., Kohno I., Manabe T. Florid endocervical glandular hyperplasia with intestinal and pyloric gland metaplasia: worrisome benign mimic of " adenoma malignum" Gynecol. Oncol. 1999, 74:504-511.
21. Kondo T., Hashi A., Murata S., Nakazawa T., Yuminamochi T., Nara M., Hoshi K., Katoh R. Endocervical adenocarcinomas associated with lobular endocervical glandular hyperplasia: a report of four cases with histochemical and immunohistochemical analyses. Mod. Pathol. 2005, 18:1199-1210.
22. Mikami Y, Kiyokawa T., Hata S., Fujiwara K., Moriya T., Sasano H., Manabe T., Akahira J., Ito K., Tase T., Yaegashi N., Sato I., Tateno H., Naganuma H. Gastrointestinal immunophenotype in adenocarcinomas of the uterine cervix and related glandular lesions: a possible link between lobular endocervical glandular hyperplasia/pyloric gland metaplasia and 'adenoma malignum'. Mod. Pathol. 2004, 17:962-972.
23. Xu J.Y., Hashi A., Kondo T., Yuminamochi T., Nara M., Hashi K., Murata S., Katoh R., Hoshi K. Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia. Int. J. Gynecol. Pathol. 2005, 24:296-302.